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Abstract 
Nemaline myopathy is a type of the heterogeneous group of congenital myopathies. Generalized 
hypotonia, weakness and delayed motor development are the main clinical features of the typical 
congenital form. Histopathology shows characteristic nemaline rods in the muscle biopsy. 
Mutations in at least seven genes, including nebulin gene (NEB) proved to be responsible for this 
muscle disease. We present a boy with nemaline myopathy type 2 (NEM2) caused by compound 
heterozygosity for two novel mutations, a deletion and a duplication in the NEB gene. The 
deletion was inherited from the father and the duplication from the mother. Testing all family 
members supports genetic counseling.  
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Introduction 
Congenital myopathies are a group of genetic muscle disorders with clinical, pathological and 
molecular heterogeneity.1 Nemaline myopathy is a pathologically well-defined subgroup of 
congenital myopathies characterized by the presence of rod-like structures in the muscle fibers.2 
The disease presents a wide range of clinical variability and severity, although generalized 
hypotonia, muscle weakness, feeding difficulties and delay of motor milestones are almost 
always present.2 All molecularly characterized forms of nemaline myopathy are autosomal, but 
inheritance can be recessive or dominant, and singleton cases may arise from de novo dominant 
mutations.2,3 To date, seven genes have been linked to this condition: α-tropomyosin (TPM3), 
nebulin (NEB), skeletal muscle α-actin (ACTA1), β-tropomyosin (TPM2), muscle troponin T1 
(TNNT1), cofilin-2 (CFL2) and the recently identified KBTBD13 gene, whose function is still 
unknown.2-4 
Disease resulting from mutations in the NEB gene is classified as nemaline myopathy type 
2 (NEM2; OMIM 256030), the most common form of nemaline myopathy.2  NEM2 is a rare 
autosomal recessive condition characterized by early onset muscle weakness, which is most 
pronounced in the axial muscles and proximal limb-girdles. Weakness in facial and bulbar 
muscles commonly results in dysarthria.5 The course of the disease is nonprogressive or slowly 
progressive and life-expectancy depends on the severity of respiratory-muscle weakness. 
Mechanical ventilation is necessary for some patients and orthopedic complications are frequent.6 
Mental development and intelligence are typically within the normal range.6 In this report we 
present the clinical and histological findings in a patient suffering from NEM2 and describe 
compound heterozygosity for two novel mutations in the NEB gene. 
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Case Report 
Clinical Presentation 
The patient, a boy was born at term from the fourth uneventful pregnancy. Birth weight was 3450 
g and Apgar scores were 9 and 10 at 5 and 10 minutes, respectively. Floppiness and weak cry 
were noticed in the neonatal period. Generalized hypotonia, weakness and delayed acquisition of 
motor milestones were observed in early childhood. He began to walk with support at the age of 
2 years. Deep tendon reflexes were reduced. There was no fasciculation in the tongue. He 
suffered also from recurrent respiratory tract infections. The serum creatine kinase activity was 
normal. The optic fundus and brain MRI were also normal  Tandem mass spectrometry and urine 
gas chromatography screening showed no evidence of inborn error of metabolism. Nerve 
conduction velocity was normal, and electromyography did not show any abnormalities. There 
was no homozygous deletion in exons 7 and 8 of the SMN1 (Survival of Motor Neuron 1) gene. 
The possibility of a congenital myopathy emerged and muscle biopsy was performed at the age of 
4 years. Severe respiratory tract infection and pneumonia led to respiratory failure later requiring 
tracheostomy and mechanical ventilation. His condition improved, however he needs ventilatory 
support during sleep. Cardiological examination did not show any abnormalities. The patient’s 
cognitive abilities were appropriate for his age. 
The patient’s parents and his three siblings (a brother and two sisters) are asymptomatic.  
Informed consent was requested from the parents prior to the muscle biopsy and molecular 
genetic studies.  
 
Muscle biopsy 
The histological work up of the muscle biopsy tissue followed standard procedures. The majority 
of the muscle fibers were hypoplastic or atrophic with large variation in fiber size. Fiber necrosis, 
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regeneration, phagocytosis, or inflammatory cell infiltration were not noted. Gomori’s trichrome 
technique detected prominent red-stained inclusion bodies in the fibers with variation in number 
and distribution. Gomori trichrome stained sections showed rod-shaped particles in the fibers 
(Figure 1a). Electronmicroscopy revealed that the rods appeared as electron-dense structures 
localized mainly along the thickened Z-lines (Figure 1b). These rod-shaped particles were 
identified as nemaline rods/bodies, and these findings were consistent with the diagnosis of  
nemaline myopathy.  
 
Genetics 
In view of the morphological findings a search was initiated in collaboration with the commercial 
diagnostic company, Centogene GmbH (Rostock, Germany) to find the molecular genetic 
etiology of nemaline myopathy in this child. Tests for ACTA1 and TPM3 were negative. 
Eventually testing the NEB gene revealed two previously unreported heterozygous mutations: a 
deletion (c.24527_24528delCT p.P8176fsX8179; Figure 2a) in exon 174 and a duplication 
(c.24250_24253dupGTCA p.T8085fsX8100; Figure 2b) in exon 171. These mutations result in a 
frameshift and a premature termination codon, respectively, presumably leading to truncated 
nebulin protein. Further testing of the parents revealed that the father carries the deletion and the 
mother has the heterozygous duplication (Figure 3). One of the two sisters of the patient carries 
wild type alleles, while another sister and the brother are heterozygous for the duplication (Figure 
3). Thus, the clinically unaffected family members carry either wild type alleles or only one of 
the mutant alleles; either the duplication or the deletion. The patient however is a compound 
heterozygous carrier of both mutations. 
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Discussion 
Nemaline myopathies are a clinically and molecularly heterogeneous group of congenital 
myopathies.1-3 The combination of characteristic clinical and histopathologic features are 
diagnostic for the disorder in most cases.1-3  The presence of red inclusions detected with Gomori 
trichrome staining and of rod-shaped particles in toluidine blue stained tissue from the patient 
strongly suggest nemaline myopathy.1-3 Ultrastructural studies reveal nemaline bodies as 
electron-dense, rod-shaped structures appearing as thickened Z-disks.1-3 Muscle imaging by MR 
can be helpful to visualize the pattern of selective muscle involvement and guide in localizing the 
site of the biopsy.7,8 
The work up of a case with nemaline myopathy is further complicated by its 
heterogeneous genetic background: seven known causative genes have been linked to this 
condition and both autosomal dominant and recessive inheritance has been observed.2,9 Six of 
these genes encode proteins associated with sarcomeric thin filaments.2 Recessive mutations in 
the NEB gene, located on chromosome 2q22-23 are the most commonly recognized cause of the 
disease.2,4. This gene has 182 exons and missense, nonsense and frameshift mutations have been 
reported.10 Hotspots have not been found and many patients proved to be compound 
heterozygotes for two mutations within the gene.2,10 The nebulin protein has a wide range of 
functions, including thin filament length specification and regulation of muscle contraction.4   
The clinical, histological and molecular genetic findings in our patient are consistent with 
the typical congenital form of nemaline myopathy type 2, caused by mutations in the NEB gene.2 
Compound heterozygosity for two novel mutations was found. A 2-base deletion 
(c.24527_24528delCT, p.P8176fsX8179) was inherited from the father and a 4-base duplication 
(c.24250_24253dupGTCA, p.T8085fsX8100) from the mother. These novel mutations led to a 
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translational frameshift and a premature termination codon in the respective translated sequences 
and thus, presumably, to truncated nebulin protein.  
 Nemaline myopathy is a debilitating condition and further research is warranted in order 
to explore the details of the molecular pathology of this disorder. These efforts are complicated 
by the heterogenic molecular background of the disease and the fact that certain genes encode 
very large proteins, like nebulin. Molecular diagnosis however becomes available for more and 
more patients supporting preimplantation or prenatal diagnosis for subsequent pregnancies.2 This 
case report extends the genetic profile of nemaline myopathy with two previously unreported 
mutations in the NEB gene. 
8 
 
Acknowledgment 
The authors are grateful for Centogene GmbH (Rostock, Germany) for performing the mutation 
analysis of the ACTA1, TPM3 and NEB genes  
 
Author Contributions 
AG and EH contributed to data collection and the first draft of the manuscript. 
TH performed the evaluation of the muscle biopsy. 
GG and HS cared for the patient 
KF and NN carried out the mutation analysis of the parents and family members.  
MS and LS were mentors who contributed equally to this work.  
 
Declaration of Conflicting Interests 
The authors declared no potential conflicts of interest with respect to the research, authorship, 
and/or publication of this article. 
 
Funding 
Supported by TÁMOP-4.2.2.A-11/1/KONV-2012-0035 grant and TÁMOP-4.2.2/B-10/1/KONV 
2010-0012 grant. 
 
Ethical Approval 
The writing/research of this article did not require ethical approval. 
9 
 
References 
 
1.  Nance JR, Dowling JJ, Gibbs EM, Bönnemann JJ. Congenital myopathies: an update. Curr 
Neurol Neurosci Rep. 2012;12:165-174. 
2.  Wallgren-Pettersson C, Sewry CA, Nowak KJ, Laing NG. Nemaline myopathies. Semin 
Pediatr Neurol. 2011;18:230-238.. 
 3. North KN. Clinical approach to the diagnosis of congenital myopathies. Semin Pediatr 
Neurol. 2011;18:216-220. 
 4. Labeit S, Ottenheijm CA, Granzier H. Nebulin, a major player in muscle health and disease. 
FASEB J. 2011;25:822-829. 
 5. Wallgren-Pettersson C. Congenital nemaline myopathy. A clinical follow-up of twelve 
patients. J Neurol Sci. 1989;89:1-14. 
 6. Wallgren-Pettersson C, Laing NG. Report of the 70th ENMC International Workshop: 
nemaline myopathy, 11-13 June 1999, Naarden, The Netherlands. Neuromuscul Disord. 
2000;10:299-306. 
 7. Fischer D, Herasse M, Ferreiro A, et al.  Muscle imaging in dominant core myopathies 
linked or unlinked to the ryanodine receptor 1 gene. Neurology 2006;67:2217-2220. 
 8. Mercuri E, Pichiecchio A, Allsop J, et al. Muscle MRI in inherited neuromuscular 
disorders: past, present, and future. J Magn Reson Imaging 2007;25:433-440. 
10 
 
 9. Wallgren-Pettersson C, Pelin K, Hilpela P, et al. Clinical and genetic heterogeneity in 
autosomal recessive nemaline myopathy. Neuromuscul Disord. 1999;9:564-572. 
 10. Wallgren-Pettersson C, Donner K, Sewry C, et al.  Mutations in the nebulin gene can cause 
severe congenital nemaline myopathy. Neuromuscul Disord. 2002;12:674-679. 
11 
 
Figure legends 
 
Figure 1. Nemaline myopathy. (a) Gomori trichrome staining of plastic-embedded semithin 
sections shows numerous rod structures in the muscle fibers. (b) Electron microscopy reveals that 
the rods are electron-dense structures. 
 
Figure 2. Identification of two novel mutations (one deletion and one duplication) in the 
NEB gene. Direct sequencing of DNA isolated from the affected patient (II/4) revealed (a) a two-
base deletion (c.24527_24528delCT) in exon 174 of the NEB gene resulting in a premature 
termination codon (p.P8176fsX8179) in the translated sequence and (b) a four-base duplication 
(c.24250_24253dupGTCA) in exon 171 of the NEB gene, resulting in frameshift 
(p.T8085fsX8100) in the translated sequence. 
 
Figure 3. Genetic screening of the affected family. The patient (II/4) and his clinically 
unaffected father (I/1) carry the deletion in heterozygous form, while the other unaffected family 
members (I/2, II/1, II/2, II/3) carry the wild type allele. The patient (II/4) and his clinically 
unaffected mother (I/2), brother (II/2) and sister (II/3) carry the duplication in heterozygous form, 
while the other unaffected family members (I/1, II/1) carry the wild type allele. These results 
suggest that the deletion is of paternal origin and the duplication is of maternal origin. The patient 
(II/4) is, thus, a compound heterozygote for these two novel mutations. 
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